A lawsuit was filed on behalf of investors in Immunomedics, Inc. (NASDAQ: IMMU) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 01/30/2019 -- An investor, who purchased shares of Immunomedics, Inc. (NASDAQ: IMMU), filed a lawsuit over alleged violations of Federal Securities Laws by Immunomedics, Inc..
Investors who purchased shares of Immunomedics, Inc. (NASDAQ: IMMU) have certain options and for certain investors are short and strict deadlines running. Deadline: February 25, 2019. NASDAQ: IMMU investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Morris Plains, NJ based Immunomedics, Inc. a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products for the targeted treatment of cancer. On December 17, 2018, FDAnews.com published an article entitled "FDA Hits Immunomedics for Data Integrity Breach." The article reported, in part, that "the FDA cited Immunomedics for a host of violations—including its handling of a data integrity breach—observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14."
The plaintiff claims that between August 23, 2018 and December 20, 2018, the Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts.
Those who purchased shares of Immunomedics, Inc. (NASDAQ: IMMU) have certain options and should contact the Shareholders Foundation.
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com